Jessica Hagen

Monica Cepak, CEO of Wisp, details how the women's telehealth company has sustained growth without raising substantial venture capital and weighs the pros and cons of venture funding.

Last year, Novo Nordisk lost its patent protection in Canada on its semaglutide-based drugs, Ozempic and Wegovy, after failing to pay a small maintenance fee to maintain it.

The deal adds prescription management, pharmacy connectivity and medication access offerings to Swoop's patient engagement platform.

The Dexcom G7 CGM sensors were originally "designated as scrap and intended for destruction" before being stolen from a third-party vendor and sold to the public.

The investment comes from Dexcom, Google Ventures and Blue Cross Blue Shield of Alabama, with availability to purchase the device through Dexcom's Stelo website.

Sychedelic closes $3.5 million for neurostimulation headphones, and Paralign Health raises $3 million to connect health plan members with in-home EMS organizations.

The new ring features predictive cardiovascular and respiratory health monitoring capabilities, clinician access and longitudinal health tracking features.

Dr. Atul Gupta, Philips' chief medical officer of diagnosis and treatment, tells MobiHealthNews about the company's partnership with Disney to help ease anxiety among children undergoing an MRI.

CVS Health Ventures led the round following a collaboration with H1 that leveraged AI to improve healthcare provider directory accuracy and patient-provider matching.

The funding round valued the company at around $965 billion, surpassing OpenAI's roughly $852 billion valuation and making it the highest-valued private AI company.